The VALTIVE1 Study Protocol: a Study for the Validation of Tie2 As the First Tumour Vascular Response Biomarker for VEGF Inhibitors
BMC Cancer(2024)
Key words
Clinical trial,Ovarian cancer,VEGFi,Tie2,Clinical decision making
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined